跳至主要内容
临床试验/EUCTR2008-008065-35-SE
EUCTR2008-008065-35-SE进行中(未招募)不适用

A multi-centre and prospective trial to evaluate the effects on mul-tiple sclerosis related fatigue during treatment with Tysabri® in patients with relapsing remitting multiple sclerosis over the course of 12 months - TYNERGY

BiogenIdec A/S0 个研究点目标入组 200 人开始时间: 2008年12月17日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Age = 18 years and age = 65 years at screening
  • Subjects who have been prescribed Tysabri® according to national guidelines but not yet started treatment
  • Signed informed consent form (ICF)
  • FSMC sum score = 43 at baseline (mild fatigue)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years)
  • F.1.3.1 Number of subjects for this age range

排除标准

  • FSMC sum score < 43 at baseline
  • History of treatment with Tysabri®
  • EDSS = 6 at baseline
  • Amphetamine as medication
  • Major depression

研究者

发起方
BiogenIdec A/S

相似试验